| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.80T | 14.72T | 14.03T | 13.95T | 12.29T | 10.36T |
| Gross Profit | 2.45T | 2.38T | 2.23T | 2.13T | 1.94T | 1.78T |
| EBITDA | 1.15T | 1.71T | 1.29T | 1.25T | 1.28T | 968.57B |
| Net Income | 916.55B | 880.25B | 801.77B | 800.52B | 820.27B | 401.43B |
Balance Sheet | ||||||
| Total Assets | 16.56T | 15.13T | 14.49T | 13.11T | 12.15T | 11.18T |
| Cash, Cash Equivalents and Short-Term Investments | 554.20B | 636.91B | 689.06B | 688.80B | 724.83B | 598.88B |
| Total Debt | 5.74T | 4.62T | 4.40T | 4.01T | 3.92T | 4.22T |
| Total Liabilities | 9.66T | 8.84T | 8.50T | 7.65T | 7.39T | 7.31T |
| Stockholders Equity | 6.32T | 5.76T | 5.43T | 4.82T | 4.20T | 3.32T |
Cash Flow | ||||||
| Free Cash Flow | 746.01B | 769.81B | 775.56B | 743.98B | 644.02B | 730.88B |
| Operating Cash Flow | 1.02T | 997.28B | 978.11B | 938.06B | 801.16B | 895.90B |
| Investing Cash Flow | -367.30B | -516.27B | -205.99B | -453.81B | 38.64B | -207.30B |
| Financing Cash Flow | -719.64B | -525.00B | -801.17B | -500.08B | -846.71B | -728.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $101.52B | 16.65 | 15.23% | 2.16% | 1.68% | 16.99% | |
69 Neutral | $150.06B | 24.26 | 31.25% | 2.24% | 7.48% | 9.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | $79.27B | 26.32 | 71.89% | 1.82% | -13.09% | -20.63% |